Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Beinborn

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Molecular Pharmacology|April 25, 2006
Class B GPCRs: a hidden agonist within?Martin Beinborn
Journal of Medicinal Chemistry|October 28, 2008
Influence of selective fluorination on the biological activity and proteolytic stability of glucagon-like peptide-1He Meng, Subrahmanian Tarakkad Krishnaji, Martin Beinborn, et al.
Scandinavian Journal of Gastroenterology|July 21, 2005
Ménétrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activityKazuhiro Watanabe, Martin Beinborn, Shinya Nagamatsu, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 29, 2007
Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalitiesGuang Liu, Jean-Philippe Fortin, Martin Beinborn, et al.
Journal of Molecular Neuroscience : MN|January 23, 2008
Pharmacological analysis of human D1 AND D2 dopamine receptor missense variantsMunya A Al-Fulaij, Yong Ren, Martin Beinborn, et al.
Molecular Pharmacology|February 24, 2004
Ligand function at constitutively active receptor mutants is affected by two distinct yet interacting mechanismsMartin Beinborn, Yong Ren, Michael Bläker, et al.
Molecular Endocrinology (Baltimore, Md.)|January 29, 2005
Basal receptor activation by locally produced glucagon-like peptide-1 contributes to maintaining beta-cell functionKai Masur, Elmi C Tibaduiza, Ci Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2007
Identification of amino acid determinants of dopamine 2 receptor synthetic agonist functionMunya A Al-Fulaij, Yong Ren, Martin Beinborn, et al.
Biochemical Pharmacology|May 7, 2003
Established theory of radiation-induced decay is not generalizable to Bolton-Hunter labeled peptidesAmanda C Doran, Yieh-Ping Wan, Alan S Kopin, et al.
Bioorganic & Medicinal Chemistry|October 28, 2008
Search for alpha-helical propensity in the receptor-bound conformation of glucagon-like peptide-1Eunice N Murage, Jonathan C Schroeder, Martin Beinborn, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Molecular Pharmacology|April 25, 2006
Class B GPCRs: a hidden agonist within?Martin Beinborn
Journal of Medicinal Chemistry|October 28, 2008
Influence of selective fluorination on the biological activity and proteolytic stability of glucagon-like peptide-1He Meng, Subrahmanian Tarakkad Krishnaji, Martin Beinborn, et al.
Scandinavian Journal of Gastroenterology|July 21, 2005
Ménétrier's disease in a patient with Helicobacter pylori infection is linked to elevated glucagon-like peptide-2 activityKazuhiro Watanabe, Martin Beinborn, Shinya Nagamatsu, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 29, 2007
Four missense mutations in the ghrelin receptor result in distinct pharmacological abnormalitiesGuang Liu, Jean-Philippe Fortin, Martin Beinborn, et al.
Journal of Molecular Neuroscience : MN|January 23, 2008
Pharmacological analysis of human D1 AND D2 dopamine receptor missense variantsMunya A Al-Fulaij, Yong Ren, Martin Beinborn, et al.
Molecular Pharmacology|February 24, 2004
Ligand function at constitutively active receptor mutants is affected by two distinct yet interacting mechanismsMartin Beinborn, Yong Ren, Michael Bläker, et al.
Molecular Endocrinology (Baltimore, Md.)|January 29, 2005
Basal receptor activation by locally produced glucagon-like peptide-1 contributes to maintaining beta-cell functionKai Masur, Elmi C Tibaduiza, Ci Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 6, 2007
Identification of amino acid determinants of dopamine 2 receptor synthetic agonist functionMunya A Al-Fulaij, Yong Ren, Martin Beinborn, et al.
Biochemical Pharmacology|May 7, 2003
Established theory of radiation-induced decay is not generalizable to Bolton-Hunter labeled peptidesAmanda C Doran, Yieh-Ping Wan, Alan S Kopin, et al.
Bioorganic & Medicinal Chemistry|October 28, 2008
Search for alpha-helical propensity in the receptor-bound conformation of glucagon-like peptide-1Eunice N Murage, Jonathan C Schroeder, Martin Beinborn, et al.
Pageof 4